Anzeige
Mehr »
Donnerstag, 21.08.2025 - Börsentäglich über 12.000 News
US-Start angekündigt: Bisher +175% Kursgewinn in 2025
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DVUC | ISIN: NZAFTE0001S4 | Ticker-Symbol:
Branche
Versorger
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
AFT PHARMACEUTICALS LIMITED Chart 1 Jahr
5-Tage-Chart
AFT PHARMACEUTICALS LIMITED 5-Tage-Chart

Aktuelle News zur AFT PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.08.AFT PHARMACEUTICALS LIMITED: Results of 2025 Annual Shareholder Meeting-
01.08.AFT Pharmaceuticals outlines shareholder value focus in 2025 AGM1
31.07.AFT PHARMACEUTICALS LIMITED: AFT ASM Presentation-
31.07.AFT PHARMACEUTICALS LIMITED: AFT ASM Release-
AFT PHARMACEUTICALS Aktie jetzt für 0€ handeln
31.07.AFT PHARMACEUTICALS LIMITED: AFT ASM Chairs Speech-
31.07.AFT PHARMACEUTICALS LIMITED: 2025 ASM Release, Chairs address & presentation-
03.07.AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Interes-
03.07.AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Intere-
03.07.AFT Pharmaceuticals - Making progress on growth strategy357AFT Pharmaceuticals has provided an investor update for Q2 CY25 (Q1 FY26), summarising material progress made across its global expansion and R&D-driven growth strategy. The highlight of the period...
► Artikel lesen
01.07.AFT Pharmaceuticals launches Combogesic IV in Canada1
30.06.AFT PHARMACEUTICALS LIMITED: June Quarter FY 2026 Investor Update-
26.06.AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Interes-
26.06.AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Intere-
26.06.AFT PHARMACEUTICALS LIMITED: Notice of Annual Meeting of Shareholders 2025-
24.06.AFT PHARMACEUTICALS LIMITED: Update - Dividend/Distribution - AFP-
24.06.AFT PHARMACEUTICALS LIMITED: Update - Dividend/Distribution - AFP-
03.06.AFT Pharmaceuticals - Setting the stage for sustained long-term growth419AFT Pharmaceuticals reported FY25 revenues of N Z$208m, posting a strong recovery in H2, with dissipating headwinds and traditional H2 seasonality offsetting the softer H1 performance. H225 revenues...
► Artikel lesen
29.05.AFT PHARMACEUTICALS LIMITED: Annual Meeting and Closing Date for Director Nominations-
26.05.Reshaped Combogesic deal sets 'pleased' AFT Pharma up to answer US demand2
22.05.HYLORIS: Hyloris Announces License Deal with AFT Pharmaceuticals for XTRAZA2
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1